Real-time enrollment status for this pancreatic cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT01954992 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 480 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Eleison Pharmaceuticals LLC. |
| Last Updated on CT.gov | December 31, 2024 (Dec 31, 2024) |
As of March 2, 2026: Clinical trial NCT01954992 is currently recruiting participants. This clinical trial study for pancreatic cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by Eleison Pharmaceuticals LLC.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01954992 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01954992 was last updated Dec 31, 2024 (December 31, 2024). HelloStudys verifies this status automatically.